Skip to content

Relay Therapeutics, Inc. RLAY Other current assets

Other current assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$4.6B-16.9%
Celcuity logo
CelcuityCELC
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
Revvity logo
RevvityRVTY
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
Roivant Sciences logo
Roivant SciencesROIV

Other financials

Income statement

See full
Revenue$3.0M-60.9%
Operating income-$78.6M+7.4%
Net income-$73.3M+4.9%
EPS (diluted)-$0.41+10.9%

Balance sheet

See full
Cash & equivalents$204.6M+119%
Total debt$31.6M-33.1%
Total equity$642.2M-10.9%
Total assets$699.6M-12.5%

Cash flow

See full
Operating cash flow-$51.1M+30.2%
CapEx$1.0K
Free cash flow-$44.9M+22.5%

Valuation

See full
Market cap$3.8B+300%

Profitability

See full
Operating margin-2,776.6%-820pp
Net margin-2,554.1%-745pp
FCF margin-1,536%-429pp

Returns & leverage

See full
Return on equity-40%-4.3pp
Debt / equity0.0×
Current ratio22.1×+2.2×

Where this comes from

Reported directly by Relay Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsCurrent.

The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Relay Therapeutics, Inc.'s other current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Relay Therapeutics, Inc.'s other current assets?
Relay Therapeutics, Inc. (RLAY) reported other current assets of $4.56M in Q1 2026.
How has Relay Therapeutics, Inc.'s other current assets changed year-over-year?
Relay Therapeutics, Inc.'s other current assets decreased by 37.9% year-over-year, from $7.35M to $4.56M.
What is the long-term trend for Relay Therapeutics, Inc.'s other current assets?
Over 4 years (2021 to 2025), Relay Therapeutics, Inc.'s other current assets has grown at a 35.7% compound annual growth rate (CAGR), from $1.76M to $5.97M.